Advertisement
Screener

INTELLIGENT BIO SOLUTIONS INC. (INBS) EBITDA

INTELLIGENT BIO SOLUTIONS INC. (INBS) EBITDA

  • 2026-03-31: Basis Reported; EBITDA (m); Operating income -$2.95M; Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$2.31M*; Operating income -$2.64M; Depreciation and amortization $327.37K*.
  • 2025-09-30: Basis Reported; EBITDA -$2.74M; Operating income (m); Depreciation and amortization (m).
  • 2025-06-30: Basis Reported; EBITDA -$2.86M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2023-06-30 to 2025-09-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-03-31Reported(m)-$2.95M(m)$1.06M(m)-$12.90K*-$4.33M*(m)(m)$2.46M(m)
2025-12-31Reported-$2.31M*-$2.64M$327.37K*$896.77K-257.41%*$68.23K*-$1.57M*(m)(m)$2.34M(m)
2025-09-30Reported-$2.74M(m)(m)(m)-246.60%$70.40K-$2.85M(m)(m)(m)(m)
2025-06-30Reported-$2.86M(m)(m)(m)-339.20%(m)(m)(m)(m)(m)(m)
2025-03-31Reported-$2.44M*-$2.56M$115.46K*$728.87K-335.43%*(m)-$2.76M*(m)(m)$2.41M(m)
2024-12-31Reported-$1.90M*-$2.26M$369.12K*$607.49K-312.00%*(m)-$2.32M*(m)(m)$1.81M(m)
2024-09-30Reported-$2.48M(m)(m)(m)-284.73%(m)-$2.39M(m)(m)(m)(m)
2024-06-30Reported-$2.58M(m)(m)(m)-355.01%(m)(m)(m)(m)(m)(m)
2024-03-31Reported-$2.69M*-$2.95M$267.46K*$823.80K-326.08%*(m)-$2.45M*(m)(m)(m)(m)
2023-12-31Reported-$1.76M*-$1.99M$231.45K*$764.06K-230.34%*(m)-$2.87M*(m)(m)$1.71M(m)
2023-09-30Reported-$2.28M(m)(m)(m)-286.24%(m)-$1.31M(m)(m)(m)(m)
2023-06-30Reported-$2.59M(m)(m)(m)-584.59%(m)(m)(m)(m)(m)(m)
2023-03-31Reported-$6.19M*-$6.54M$352.95K*$457.06K-1354.41%*(m)-$2.52M*(m)(m)(m)(m)
2022-12-31Reported(m)-$2.13M(m)$356.68K(m)(m)-$2.38M*(m)(m)$2.25M(m)
2022-09-30Reported(m)-$1.22M(m)$311.32K(m)(m)-$1.89M(m)(m)(m)(m)
2022-03-31Reported(m)-$1.34M(m)$192.50K(m)(m)-$292.22K*(m)(m)(m)(m)
2021-12-31Reported(m)-$3.47M(m)(m)(m)(m)-$1.43M*(m)(m)(m)(m)
2021-09-30Reported(m)-$1.44M(m)(m)(m)(m)$82.96K(m)(m)(m)(m)
2021-03-31Reported(m)-$3.14M(m)$34.29K(m)(m)-$6.16M*(m)(m)(m)(m)
2020-12-31Reported(m)-$917.33K(m)(m)(m)(m)-$776.97K*(m)$341.82K(m)(m)
2020-09-30Reported(m)-$663.00K(m)(m)(m)(m)-$2.68M(m)(m)(m)(m)
2020-03-31Reported(m)-$28.82K(m)(m)(m)(m)-$218.65K*(m)(m)(m)(m)
2019-12-31Reported(m)-$1.70M(m)(m)(m)(m)(m)(m)$494.67K(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported(m)-$12.61M(m)$4.22M(m)$125.73K-$11.93M(m)(m)$10.50M(m)
2025-06-30Reported-$9.71M(m)(m)(m)-318.07%$231.84K-$9.68M(m)(m)$8.92M(m)
2024-06-30Reported-$9.31M(m)(m)(m)-299.15%$221.43K-$9.57M(m)(m)(m)(m)
2023-06-30Reported-$11.78M(m)(m)(m)-937.31%(m)-$7.38M(m)(m)(m)(m)
2022-06-30Reported(m)-$8.34M(m)$437.15K(m)(m)-$3.36M(m)(m)(m)(m)
2021-06-30Reported(m)-$5.57M(m)$1.98M(m)(m)-$11.30M(m)(m)(m)(m)
2020-06-30Reported(m)-$2.86M(m)(m)(m)(m)-$498.62K(m)(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
AETHLON MEDICAL INC (AEMD)United States$0.005B
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26